Allegra Freelander 34th Lorne Cancer Conference 2022

Abstracts this author is presenting:

• Combination CDK4/6 inhibition and AR agonism suppresses the growth of CDK4/6 inhibitor resistant breast cancers — Welcome Function and Poster Session 1